TOKYO, Dec. 09, 2024 — MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), a comprehensive healthcare provider operating over 300 wellness centers across Japan, today announced the pricing of its public offering. The offering consists of 2,860,000 American Depositary Shares (ADSs) priced at $1.75 per share, generating anticipated gross proceeds of approximately $5,000,000, before accounting for underwriting discounts and expenses. Underwriters have a 45-day option to purchase up to an additional 429,000 ADSs to cover over-allotments at the public offering price, less the underwriting discount. The offering is scheduled to close on December 11, 2024, contingent upon customary closing conditions.
MEDIROM plans to allocate the proceeds to working capital and general corporate purposes, potentially including investments, acquisitions, or strategic partnerships to expand its customer base and promote new services.
ThinkEquity serves as the sole book-running manager for the offering.
A registration statement on Form F-1 (File No. 333-281771) for these shares has been filed with and declared effective by the Securities and Exchange Commission (SEC) on December 9, 2024. This offering is exclusively available through a prospectus. Prospectus copies can be obtained from ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004.
This press release does not constitute an offer to sell or a solicitation of an offer to buy securities, and no sales will occur in any jurisdiction where such offers, solicitations, or sales would be illegal before registration or qualification under the relevant securities laws.
About MEDIROM Healthcare Technologies Inc.
MEDIROM, a holistic healthcare company, operates over 300 wellness salons in Japan, with Re.Ra.Ku® as its flagship brand, and provides healthcare services. In 2015, MEDIROM expanded into health technology, launching the “Lav®” on-demand training app. Entering the device market in 2020, the company developed the “MOTHER Bracelet®” smart tracker. In 2023, MEDIROM introduced REMONY, a remote monitoring system for corporate clients, securing orders across various sectors including nursing care, transportation, construction, and manufacturing. MEDIROM aims to leverage its diverse healthcare offerings to collect and manage user data, aspiring to become a leader in healthcare big data. For more information, visit .
Forward-Looking Statements Regarding MEDIROM
This press release contains forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements, including projections of operational results, financial condition, business strategies, market opportunities, competitive standing, industry trends, and growth prospects, involve known and unknown risks and uncertainties that may cause actual results to differ materially. Forward-looking statements may be identified by words such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or similar expressions. These statements are subject to various risks and uncertainties, and reliance on them should be avoided. Any forward-looking statements represent MEDIROM’s current views and are subject to risks related to its operations, results, growth strategy, and financial position.
Contact:
Investor Relations Team
E-mail:
